A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.

by Javier Castillo-Olivares, Eva Calvo-Pinilla, Isabel Casanova, Katarzyna Bachanek-Bankowska, Rachael Chiam, Sushila Maan, Jose Maria Nieto, Javier Ortego, Peter Paul Clement Mertens
Published 2011-01-01